QDR

Plazomicin Test System, Immunoassay

Product code
QDR
Device name
Plazomicin Test System, Immunoassay
Device class
Class 2
21 CFR
21 CFR 862.3460
Medical specialty
Clinical Toxicology
Marketing pathway
510(K)
Flag
Third-party review eligible
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

A plazomicin test system is a device intended to measure plazomicin in human specimens. Measurements obtained by this device are used in monitoring levels of plazomicin to ensure appropriate therapy in patients with complicated urinary tract infection.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: QDR
Classification and pathway per current FDA publications. Data from openFDA (CC0).